This site provides INTERCEPT product information for International audiences Select your region
Proven in Routine Use
Regulatory authorities concluded that INTERCEPT Platelets and Plasma are not clinically different from untreated products and may be prescribed and transfused in accordance with standard infusion methods.
The INTERCEPT Blood System is currently used to inactivate pathogens in platelets and plasma across Europe, CIS, the Middle East and USA.
The INTERCEPT™ Blood System is designed to reduce the risk of transfusion-transmitted diseases.